Successful treatment of encapsulating peritoneal sclerosis by hemodialysis and peritoneal lavage using dialysate containing dissolved hydrogen.
Terawaki H, Nakano H, Zhu WJ, Nakayama M. · Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis · 2015
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB PLAIN-LANGUAGE TAKEAWAY
The study adds to the molecular-hydrogen evidence base, but the available record does not support a firm conclusion about therapeutic benefit.
Molecular hydrogen dialysis study 2015: what the findings mean
This H2HUBB page translates the technical study record into consumer-friendly language while preserving the scientific details. The publication “Successful treatment of encapsulating peritoneal sclerosis by hemodialysis and peritoneal lavage using dialysate containing dissolved hydrogen.” was classified as Case report or case series using Human clinical evidence. The complete source should be reviewed because a detailed plain-language summary was not available in the structured record.
Publication: Terawaki H, Nakano H, Zhu WJ, Nakayama M., Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 2015.
What the researchers studied
The researchers examined how molecular hydrogen related to dialysis. The available structured record did not clearly identify one primary outcome, so the original source should be checked for the complete endpoint definitions.
What effects did molecular hydrogen have?
Observed hydrogen effects: A clear hydrogen-specific results statement could not be extracted from the available structured record. Review the original publication before interpreting hydrogen’s effects.
Why these findings matter
The available record suggests a reason to continue studying hydrogen, but it does not provide enough information for a firm therapeutic conclusion.
How strong is this evidence?
This is early human evidence from a case report or case series, which can identify a promising signal but cannot establish cause and effect.
Technical study details
- Publication type: Case report or case series
- Evidence type: Human clinical evidence
- Hydrogen method: Other or not reported
Limitations and safety
Important limitations: A case report or case series has no randomized comparison group and cannot determine whether hydrogen caused the reported change.
Safety information: The available structured record did not provide a separate safety conclusion. This does not mean adverse events were assessed or absent.
Original study and H2HUBB research context
This page explains a published research record and does not turn one study into a medical recommendation. Read the original scientific source for the complete methods, statistics, and author conclusions. Compare this result with related evidence in the H2HUBB Molecular Hydrogen Research Library.